Cash flow GSK plc

Equities

GSK

GB00BN7SWP63

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 14:46:14 20/05/2026 BST			5-day change	1st Jan Change
1,910.50 ^GBX	+0.45%		+1.38%	+4.80%

02:16pm	GSK and the pan-canadian pharmaceutical alliance (pcpa) initiate negotiations for blenrep for the treatment of relapsed or refractory multiple myeloma	RE
05-18	UK Shares Start Week in Green as IMF Lifts UK Growth Outlook, Politics in Focus	MT

0d1e040dd8e37835f1b.covlCRKmG_nEizCOHF1Vb_H0t54qs3JADjcfVsoW1go.Kv_TSkHjdL2v1Hm5eGsKP7y99q1b9Cc3X29eIL5A5Xs6zIY_aMFht4redQ

Published financial data: GSK PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	34.11B	29.32B	30.33B	31.38B	32.67B
Total Revenues	34.11B	29.32B	30.33B	31.38B	32.67B
Cost of Goods Sold, Total	11.45B	9.41B	8.39B	8.84B	8.95B
Gross Profit	22.66B	19.92B	21.94B	22.53B	23.72B
Selling General & Admin Expenses, Total	10.19B	8.18B	9.16B	10.85B	9.01B
R&D Expenses	4.88B	5.15B	5.82B	6.08B	6.65B
Other Operating Expenses	-373M	-737M	-1.44B	-584M	-1.39B
Other Operating Expenses, Total	14.69B	12.6B	13.54B	16.34B	14.27B
Operating Income	7.97B	7.32B	8.4B	6.19B	9.45B
Interest Expense, Total	-775M	-819M	-710M	-615M	-658M
Interest And Investment Income	26M	62M	108M	132M	147M
Net Interest Expenses	-749M	-757M	-602M	-483M	-511M
Income (Loss) On Equity Invest.	33M	-2M	-5M	-3M	1M
Other Non Operating Income (Expenses)	-4M	-46M	-75M	-63M	-21M
EBT, Excl. Unusual Items	7.25B	6.52B	7.72B	5.64B	8.92B
Restructuring Charges	-628M	-321M	-382M	-354M	-109M
Gain (Loss) On Sale Of Investments	1M	256M	-121M	57M	-24M
Gain (Loss) On Sale Of Assets	591M	215M	61M	246M	106M
Asset Writedown	-322M	-296M	-398M	-320M	-888M
Legal Settlements	-52M	922M	-	-	-
Other Unusual Items	-1.39B	-1.66B	-817M	-1.79B	-600M
EBT, Incl. Unusual Items	5.44B	5.63B	6.06B	3.48B	7.4B
Income Tax Expense	346M	707M	756M	526M	1.11B
Earnings From Continuing Operations	5.1B	4.92B	5.31B	2.95B	6.29B
Earnings Of Discontinued Operations	-	10.5B	-	-	-
Net Income to Company	5.1B	15.42B	5.31B	2.95B	6.29B
Minority Interest	-711M	-460M	-380M	-376M	-573M
Net Income - (IS)	4.38B	14.96B	4.93B	2.58B	5.72B
Net Income to Common Incl Extra Items	4.38B	14.96B	4.93B	2.58B	5.72B
Net Income to Common Excl. Extra Items	4.38B	4.46B	4.93B	2.58B	5.72B
Per Share Items
Net EPS - Basic	1.1	3.71	1.22	0.63	1.41
Basic EPS - Continuing Operations	1.1	1.11	1.22	0.63	1.41
Basic Weighted Average Shares Outstanding	4B	4.03B	4.05B	4.08B	4.05B
Net EPS - Diluted	1.08	3.66	1.2	0.62	1.39
Diluted EPS - Continuing Operations	1.08	1.09	1.2	0.62	1.39
Diluted Weighted Average Shares Outstanding	4.05B	4.08B	4.11B	4.14B	4.12B
Normalized Basic EPS	0.95	0.9	1.1	0.77	1.23
Normalized Diluted EPS	0.94	0.88	1.08	0.76	1.21
Dividend Per Share	1	0.61	0.58	0.61	0.66
Payout Ratio	91.2	23.18	45.6	94.91	44.86
American Depositary Receipts Ratio (ADR)	2	2	2	2	2
Supplemental Items
EBITDA	9.9B	9.47B	10.3B	8.32B	11.34B
EBITA	8.92B	8.41B	9.41B	7.43B	10.48B
EBIT	7.97B	7.32B	8.4B	6.19B	9.45B
EBITDAR	9.92B	9.49B	10.33B	8.35B	-
Effective Tax Rate - (Ratio)	6.36	12.56	12.47	15.13	15.02
Total Current Taxes	1.35B	1.49B	1.62B	1.55B	1.4B
Total Deferred Taxes	-1B	-784M	-865M	-1.03B	-283M
Normalized Net Income	3.82B	3.61B	4.45B	3.15B	5B
Interest Capitalized	16M	21M	36M	20M	15M
Interest on Long-Term Debt	47M	51M	74M	46M	46M
Non-Cash Pension Expense	50M	37M	73M	64M	18M
Supplemental Operating Expense Items
Advertising Expense	1.81B	735M	835M	851M	738M
Selling and Marketing Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	5.28B	5.49B	6.22B	6.4B	7.52B
Net Rental Expense, Total	20M	17M	27M	30M	-
Imputed Operating Lease Interest Expense	4.93M	5.06M	8.26M	8.71M	-
Imputed Operating Lease Depreciation	15.07M	11.94M	18.74M	21.29M	-
Stock-Based Comp., Other (Total)	404M	346M	307M	344M	374M
Total Stock-Based Compensation	404M	346M	307M	344M	374M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	4.27B	3.72B	2.94B	3.87B	3.4B
Short Term Investments	614M	750M	42M	21M	9M
Trading Asset Securities, Total	77M	4.25B	2.3B	75M	15M
Total Cash And Short Term Investments	4.96B	8.72B	5.28B	3.97B	3.42B
Accounts Receivable, Total	6.25B	5.45B	5.9B	5.56B	5.91B
Other Receivables	1.21B	969M	1.49B	1.36B	1.45B
Notes Receivable	18M	11M	9M	7M	11M
Total Receivables	7.48B	6.43B	7.4B	6.94B	7.37B
Inventory	5.78B	5.15B	5.5B	5.67B	5.92B
Prepaid Expenses	315M	343M	355M	390M	385M
Other Current Assets, Total	133M	123M	108M	37M	406M
Total Current Assets	18.67B	20.77B	18.64B	17B	17.51B
Gross Property Plant And Equipment	20.7B	19.36B	19.59B	19.92B	20.2B
Accumulated Depreciation	-10.02B	-9.74B	-9.63B	-9.84B	-10.15B
Net Property Plant And Equipment	10.67B	9.62B	9.96B	10.07B	10.05B
Long-term Investments	2.28B	1.58B	1.19B	1.2B	1.13B
Goodwill	10.55B	7.05B	6.81B	6.98B	7.02B
Other Intangibles, Total	30.08B	14.32B	14.77B	15.52B	16.75B
Deferred Tax Assets Long-Term	5.22B	5.66B	6.05B	6.76B	6.52B
Other Long-Term Assets, Total	1.63B	1.16B	1.58B	1.94B	2.15B
Total Assets	79.1B	60.15B	59B	59.46B	61.12B
Liabilities
Accounts Payable, Total	4.54B	3.87B	3.72B	3.46B	3.54B
Accrued Expenses, Total	9.97B	4.04B	4.08B	4.06B	4.35B
Short-term Borrowings	707M	1.49B	893M	-	1.08B
Current Portion of Long-Term Debt	2.69B	2.3B	1.76B	2.18B	1.8B
Current Portion of Leases	203M	167M	156M	168M	137M
Current Income Taxes Payable	489M	471M	500M	703M	498M
Unearned Revenue Current, Total	307M	299M	222M	171M	153M
Other Current Liabilities	4.76B	10.19B	9.73B	10.95B	9.84B
Total Current Liabilities	23.67B	22.81B	21.07B	21.7B	21.39B
Long-Term Debt	19.76B	16.19B	14.15B	13.7B	14.08B
Long-Term Leases	812M	841M	1.05B	934M	693M
Unearned Revenue Non Current	85M	83M	254M	165M	121M
Pension & Other Post Retirement Benefits	3.11B	2.58B	2.34B	1.86B	1.69B
Deferred Tax Liability Non Current	3.56B	289M	311M	382M	291M
Other Non Current Liabilities	6.76B	7.25B	7.03B	7.63B	6.9B
Total Liabilities	57.76B	50.05B	46.21B	46.38B	45.16B
Common Stock, Total	1.35B	1.35B	1.35B	1.35B	1.35B
Additional Paid In Capital	3.3B	3.44B	3.45B	3.47B	3.5B
Retained Earnings	8.75B	4.79B	7.74B	8.77B	10.96B
Comprehensive Income and Other	1.66B	1.02B	805M	83M	573M
Total Common Equity	15.06B	10.6B	13.35B	13.67B	16.38B
Minority Interest	6.29B	-502M	-552M	-585M	-421M
Total Equity	21.34B	10.1B	12.8B	13.09B	15.96B
Total Liabilities And Equity	79.1B	60.15B	59B	59.46B	61.12B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.01B	4.03B	4.06B	4.08B	4.01B
ECS Total Common Shares Outstanding	4.01B	4.03B	4.06B	4.08B	4.01B
Book Value / Share	3.76	2.63	3.29	3.35	4.08
Tangible Book Value	-25.58B	-10.77B	-8.23B	-8.83B	-7.39B
Tangible Book Value Per Share	-6.38	-2.67	-2.03	-2.16	-1.84
Total Debt	24.17B	20.99B	18.02B	16.99B	17.79B
Net Debt	19.21B	12.26B	12.74B	13.02B	14.37B
Debt Equivalent of Unfunded Proj. Benefit Obligation	1.13B	1.36B	763M	103M	-229M
Debt Equivalent Oper. Leases	160M	136M	216M	240M	-
Minority Interest, Total (Incl. Fin. Div)	6.29B	-502M	-552M	-585M	-421M
Equity Method Investments, Total	88M	74M	55M	96M	89M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	1.77B	1.58B	1.59B	1.36B	608M
Inventories - Work In Process, Total	1.89B	2.29B	2.45B	2.68B	3.7B
Inventories - Finished Goods, Total	2.12B	1.28B	1.46B	1.62B	1.62B
Land - (BS)	6.95B	6.39B	6.22B	6.12B	5.83B
Machinery, Total	11.3B	10.48B	10.34B	10.64B	11.13B
Full Time Employees	90.1K	69.4K	70.21K	68.63K	66.84K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	150M	91M	85M	99M	75M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	4.38B	14.96B	4.93B	2.58B	5.72B
Depreciation & Amortization - CF	1.2B	1.06B	1.08B	1.1B	1.06B
Amortization of Goodwill and Intangible Assets - (CF)	957M	1.09B	1.01B	1.24B	1.04B
Depreciation & Amortization, Total	2.15B	2.15B	2.09B	2.34B	2.09B
Amortization of Deferred Charges, Total - (CF)	225M	-	203M	211M	220M
(Gain) Loss From Sale Of Asset	-606M	-221M	-12M	-159M	-40M
(Gain) Loss on Sale of Investments - (CF)	28M	-1M	-1M	-16M	-4M
Asset Writedown & Restructuring Costs	523M	198M	360M	369M	1.14B
(Income) Loss On Equity Investments - (CF)	-33M	2M	5M	3M	-1M
Stock-Based Compensation (CF)	367M	346M	307M	344M	374M
Net Cash From Discontinued Operations	-	769M	-	-	-
Other Operating Activities, Total	714M	-9.44B	-257M	631M	141M
Change In Accounts Receivable	-782M	-158M	-794M	298M	-613M
Change In Inventories	25M	-269M	-424M	-294M	-140M
Change In Accounts Payable	284M	494M	-15M	-179M	131M
Change in Other Net Operating Assets	670M	-1.42B	377M	431M	-1.28B
Cash from Operations	7.95B	7.4B	6.77B	6.55B	7.74B
Capital Expenditure	-1.17B	-1.14B	-1.31B	-1.4B	-1.35B
Sale of Property, Plant, and Equipment	143M	146M	28M	65M	24M
Cash Acquisitions	-114M	-3.19B	-1.47B	-824M	-1.71B
Divestitures	-17M	-43M	49M	-18M	-27M
Sale (Purchase) of Intangible assets	-987M	-919M	-1.02B	-1.45B	-1.52B
Investment in Marketable and Equity Securities, Total	334M	95M	1.78B	2.23B	108M
Other Investing Activities, Total	36M	-3.72B	346M	168M	241M
Cash from Investing	-1.78B	-8.77B	-1.6B	-1.23B	-4.23B
Short Term Debt Issued, Total	318M	1.02B	-	266M	1.22B
Long-Term Debt Issued, Total	-	1.02B	223M	1.08B	1.98B
Total Debt Issued	318M	2.05B	223M	1.34B	3.19B
Short Term Debt Repaid, Total	-2.31B	-5.07B	-2.45B	-892M	-288M
Long-Term Debt Repaid, Total	-215M	-1.8B	-341M	-1.84B	-1.64B
Total Debt Repaid	-2.53B	-6.87B	-2.79B	-2.73B	-1.93B
Issuance of Common Stock	21M	25M	10M	20M	15M
Repurchase of Common Stock	-	-	-	-	-1.38B
Common Dividends Paid	-4B	-3.47B	-2.25B	-2.44B	-2.56B
Common & Preferred Stock Dividends Paid	-4B	-3.47B	-2.25B	-2.44B	-2.56B
Special Dividend Paid	-	-	-	-	-
Other Financing Activities, Total	-1.4B	9.09B	-837M	-910M	-1.02B
Cash from Financing	-7.59B	823M	-5.64B	-4.73B	-3.68B
Foreign Exchange Rate Adjustments	-29M	152M	-99M	-54M	-19M
Net Change in Cash	-1.44B	-394M	-567M	545M	-196M
Supplemental Items
Cash Interest Paid	786M	848M	766M	632M	679M
Cash Income Tax Paid (Refund)	1.29B	1.31B	1.33B	1.31B	1.2B
Levered Free Cash Flow	6.47B	4.95B	3.84B	4.95B	3.28B
Unlevered Free Cash Flow	6.95B	5.46B	4.28B	5.34B	3.7B
Change In Net Working Capital	-1.35B	-454M	1.24B	-1.43B	2.03B
Net Debt Issued / Repaid	-2.21B	-4.82B	-2.57B	-1.39B	1.26B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.24	6.57	8.82	6.53	9.79
Return on Total Capital	10.65	11.95	16.97	12.71	18.5
Return On Equity %	24.18	31.31	46.38	22.8	43.31
Return on Common Equity	29.59	34.78	41.16	19.06	38.05
Margin Analysis
Gross Profit Margin %	66.42	67.92	72.34	71.81	72.61
SG&A Margin	29.87	27.89	30.19	34.57	27.59
EBITDA Margin %	29.04	32.29	33.98	26.51	34.7
EBITA Margin %	26.16	28.67	31.03	23.69	32.1
EBIT Margin %	23.35	24.97	27.71	19.73	28.92
Income From Continuing Operations Margin %	14.94	16.78	17.5	9.41	19.25
Net Income Margin %	12.85	51	16.25	8.21	17.5
Net Avail. For Common Margin %	12.85	15.21	16.25	8.21	17.5
Normalized Net Income Margin	11.19	12.32	14.66	10.04	15.3
Levered Free Cash Flow Margin	18.96	16.88	12.65	15.79	10.05
Unlevered Free Cash Flow Margin	20.38	18.62	14.12	17.02	11.31
Asset Turnover
Asset Turnover	0.43	0.42	0.51	0.53	0.54
Fixed Assets Turnover	3.15	2.89	3.1	3.13	3.25
Receivables Turnover (Average Receivables)	5.78	5.01	5.34	5.47	5.69
Inventory Turnover (Average Inventory)	1.94	1.72	1.58	1.58	1.54
Short Term Liquidity
Current Ratio	0.79	0.91	0.88	0.78	0.82
Quick Ratio	0.52	0.66	0.6	0.5	0.5
Operating Cash Flow to Current Liabilities	0.34	0.32	0.32	0.3	0.36
Days Sales Outstanding (Average Receivables)	63.1	72.8	68.34	66.89	64.11
Days Outstanding Inventory (Average Inventory)	187.68	212.03	231.58	231.04	236.47
Average Days Payable Outstanding	144.36	174.82	158.34	145.73	138.77
Cash Conversion Cycle (Average Days)	106.41	110.01	141.58	152.19	161.82
Long Term Solvency
Total Debt/Equity	113.27	207.87	140.82	129.8	111.48
Total Debt / Total Capital	53.11	67.52	58.48	56.48	52.71
LT Debt/Equity	96.4	168.73	118.84	111.85	92.6
Long-Term Debt / Total Capital	45.2	54.8	49.35	48.67	43.79
Total Liabilities / Total Assets	73.02	83.21	78.32	77.99	73.89
EBIT / Interest Expense	10.28	8.94	11.84	10.07	14.36
EBITDA / Interest Expense	13.06	11.56	14.78	13.87	17.54
(EBITDA - Capex) / Interest Expense	11.54	10.17	12.93	11.6	15.49
Total Debt / EBITDA	2.39	2.22	1.72	1.99	1.54
Net Debt / EBITDA	1.9	1.29	1.21	1.53	1.24
Total Debt / (EBITDA - Capex)	2.7	2.52	1.96	2.38	1.75
Net Debt / (EBITDA - Capex)	2.15	1.47	1.39	1.83	1.41
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	0.04	18.74	3.42	3.46	4.11
Gross Profit, 1 Yr. Growth %	-2.37	19.53	10.16	2.69	5.28
EBITDA, 1 Yr. Growth %	-4.47	22.09	13.37	-19.42	36.25
EBITA, 1 Yr. Growth %	-4.86	25.08	14.72	-21.19	41.06
EBIT, 1 Yr. Growth %	-6.09	29.96	14.76	-26.51	52.62
Earnings From Cont. Operations, 1 Yr. Growth %	-20.23	39.96	7.86	-44.4	113.11
Net Income, 1 Yr. Growth %	-23.73	241.07	-67.05	-47.75	121.98
Normalized Net Income, 1 Yr. Growth %	-8.14	25.89	23.04	-29.36	58.73
Diluted EPS Before Extra, 1 Yr. Growth %	-24.1	33.5	9.8	-48.12	123.15
Accounts Receivable, 1 Yr. Growth %	12.56	-12.71	8.31	-5.79	6.29
Inventory, 1 Yr. Growth %	-3.55	-11.02	6.84	3.11	4.5
Net Property, Plant and Equip., 1 Yr. Growth %	-3.03	-9.86	3.5	1.16	-0.25
Total Assets, 1 Yr. Growth %	-1.65	-23.96	-1.9	0.78	2.78
Tangible Book Value, 1 Yr. Growth %	-1	-57.91	-23.54	7.22	-16.28
Common Equity, 1 Yr. Growth %	3.21	-29.6	25.94	2.43	19.79
Cash From Operations, 1 Yr. Growth %	-5.79	-6.9	-8.58	-3.16	18.11
Capital Expenditures, 1 Yr. Growth %	-4.4	20.32	14.96	6.47	-3.65
Levered Free Cash Flow, 1 Yr. Growth %	-19.66	2.11	-10.06	28.7	-33.71
Unlevered Free Cash Flow, 1 Yr. Growth %	-19.04	2.59	-10.41	24.35	-30.78
Dividend Per Share, 1 Yr. Growth %	0	-38.75	-5.31	5.17	8.2
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.53	9.73	10.82	3.44	3.78
Gross Profit, 2 Yr. CAGR %	-0.66	8.14	14.75	6.36	3.98
EBITDA, 2 Yr. CAGR %	-2.04	8.12	15.26	-5.39	3.87
EBITA, 2 Yr. CAGR %	-2.07	8.85	18.33	-5.98	4.43
EBIT, 2 Yr. CAGR %	-1.44	10.01	22.13	-8.05	6.03
Earnings From Cont. Operations, 2 Yr. CAGR %	-1.65	-1.8	22.87	-22.56	8.85
Net Income, 2 Yr. CAGR %	-2.84	61.29	6.01	-58.51	7.7
Normalized Net Income, 2 Yr. CAGR %	-2.82	8.92	24.46	-6.65	6.04
Diluted EPS Before Extra, 2 Yr. CAGR %	-3.29	-4.96	21.07	-24.53	7.59
Accounts Receivable, 2 Yr. CAGR %	6.69	-0.88	-2.77	1.01	0.07
Inventory, 2 Yr. CAGR %	-1.39	-7.36	-2.5	4.96	3.8
Net Property, Plant and Equip., 2 Yr. CAGR %	-2.88	-6.51	-3.41	2.33	0.46
Total Assets, 2 Yr. CAGR %	-0.37	-13.52	-13.63	-0.57	1.77
Tangible Book Value, 2 Yr. CAGR %	-7.84	-35.44	-43.27	-9.46	-5.26
Common Equity, 2 Yr. CAGR %	14.89	-14.76	-5.84	13.58	10.77
Cash From Operations, 2 Yr. CAGR %	-0.42	-6.35	-7.74	-5.91	6.95
Capital Expenditures, 2 Yr. CAGR %	-3.75	7.5	17.61	10.63	1.29
Levered Free Cash Flow, 2 Yr. CAGR %	16.28	-5.67	-11.03	7.76	-7.49
Unlevered Free Cash Flow, 2 Yr. CAGR %	14.19	-5.3	-10.32	5.7	-7.09
Dividend Per Share, 2 Yr. CAGR %	0	-21.74	-23.84	-0.2	6.67
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.44	-4.58	7.59	8.31	3.66
Gross Profit, 3 Yr. CAGR %	2.39	-4.63	8.8	10.58	6
EBITDA, 3 Yr. CAGR %	1.94	-2.83	8.35	2.36	6.85
EBITA, 3 Yr. CAGR %	2.05	-3.32	9.87	3.41	7.64
EBIT, 3 Yr. CAGR %	2.05	-3.71	11.57	3.19	8.86
Earnings From Cont. Operations, 3 Yr. CAGR %	7.99	-2.25	1.32	-5.67	8.52
Net Income, 3 Yr. CAGR %	6.57	47.66	-5.01	-16.26	-27.43
Normalized Net Income, 3 Yr. CAGR %	-0.23	-3.67	13.44	3.15	11.42
Diluted EPS Before Extra, 3 Yr. CAGR %	5.91	-1.92	-0.28	-8.73	8.32
Accounts Receivable, 3 Yr. CAGR %	6.46	-0.21	2.09	-3.79	2.74
Inventory, 3 Yr. CAGR %	1.83	-4.71	-2.85	-0.66	4.8
Net Property, Plant and Equip., 3 Yr. CAGR %	-1.18	-5.26	-3.28	-1.91	1.46
Total Assets, 3 Yr. CAGR %	10.86	-8.95	-9.81	-9.07	0.54
Tangible Book Value, 3 Yr. CAGR %	10.01	-29.03	-31.7	-29.86	-11.79
Common Equity, 3 Yr. CAGR %	58.5	-2.42	-2.92	-3.16	15.61
Cash From Operations, 3 Yr. CAGR %	-1.89	-2.63	-7.1	-6.24	1.5
Capital Expenditures, 3 Yr. CAGR %	-4.46	-3.32	9.93	13.77	5.65
Levered Free Cash Flow, 3 Yr. CAGR %	35.45	1.15	-11.64	0.73	-8.35
Unlevered Free Cash Flow, 3 Yr. CAGR %	48.33	0.81	-11.09	0.1	-8.21
Dividend Per Share, 3 Yr. CAGR %	0	-15.08	-16.6	-15.19	2.52
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.11	-0.58	-0.32	-1.45	6.05
Gross Profit, 5 Yr. CAGR %	3.61	-0.93	0.78	-0.38	6.85
EBITDA, 5 Yr. CAGR %	7	1.84	1.96	-4.22	6.95
EBITA, 5 Yr. CAGR %	7.96	1.89	2.31	-4.39	8.12
EBIT, 5 Yr. CAGR %	8.54	1.73	2.31	-5.47	9.32
Earnings From Cont. Operations, 5 Yr. CAGR %	36.84	17.8	5.58	-10.94	4.27
Net Income, 5 Yr. CAGR %	36.9	57.73	6.35	-11.13	-0.12
Normalized Net Income, 5 Yr. CAGR %	6.78	2.71	2.95	-4.87	10.42
Diluted EPS Before Extra, 5 Yr. CAGR %	36.02	23.02	5.64	-11.68	2.8
Accounts Receivable, 5 Yr. CAGR %	6.24	3.14	2.67	0.28	1.28
Inventory, 5 Yr. CAGR %	2.54	-1.52	0.08	-0.95	-0.24
Net Property, Plant and Equip., 5 Yr. CAGR %	-0.25	-2.4	-2.08	-2.3	-1.8
Total Assets, 5 Yr. CAGR %	6.01	1.3	0.32	-5.69	-5.34
Tangible Book Value, 5 Yr. CAGR %	1.61	-14.36	-15.59	-21.76	-22.15
Common Equity, 5 Yr. CAGR %	68.03	174.5	28.69	3.69	2.34
Cash From Operations, 5 Yr. CAGR %	4.12	1.36	-4.28	-3.96	-1.72
Capital Expenditures, 5 Yr. CAGR %	-5.35	-5.85	-0.45	2.03	6.39
Levered Free Cash Flow, 5 Yr. CAGR %	6.85	-16.78	8.08	0.71	-10
Unlevered Free Cash Flow, 5 Yr. CAGR %	6.46	-15.72	14.99	0.03	-9.51
Dividend Per Share, 5 Yr. CAGR %	0	-9.34	-10.32	-9.41	-7.97